Edith Falcon de Legal

Dr. Edith Falcon de Legal

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Cancer Epidemiology
Verified
Journal Article
Closed access
ELEdith Falcon de Legal
Edith Falcon de Legal
MAMarta Ascurra
Marta Ascurra
GCGislaine Custodio
Gislaine Custodio
Horacio Legal AyalaHoracio Legal Ayala
Horacio Legal Ayala
MMMagna Monteiro
Magna Monteiro
BFBonald Figueiredo
Bonald Figueiredo

13 November 2024 in Data in Brief
Verified
Journal Article
Open access
BGBenicio Grossling-Vallejos
Benicio Grossling-Vallejos
CVCarolina Villegas
Carolina Villegas
RRRonald Rivas
Ronald Rivas
MPMaría Gloria Pedrozo
María Gloria Pedrozo
GGGraciela Giménez
Graciela Giménez
ELEdith Falcon de Legal
Edith Falcon de Legal
This article presents a dataset containing 641 images of Thyroid Gammagraphies studies corresponding to 235 patients over 18 years of age that were acquired in the period from 2016 to 2024 at the Nuclear Medicine Service of the Instituto de Investigaciones en Ciencias de la Salud of the Universidad Nacional de Asunción (IICS - UNA), Paraguay. First, the Thyroid Gammagraphies images were acquired according to the acquisition protocol described in this article. The thyroid scintigraphies images were acquired using trimodal SPECT-CT-PET equipment, model AnyScan SCP, MEDISO brand. The images were classified by the professionals of the Nuclear Medicine Service according to the diagnoses made by the nuclear physicians. They were grouped into toxic adenoma, diffuse goiter, multinodular goiter, nodular goiter, absent thyroid gland (total thyroidectomy), preserved thyroid gland, deformed thyroid gland, right hemithyroidectomy, autonomous nodule, hyperuptake nodule, hypouptake nodule, remnant after total thyroidectomy, iatrogenically blocked thyroid, De Quervain's subacute thyroiditis, and combined cases of diffuse or multinodular goiter with subacute thyroiditis. The generated dataset will be helpful for nuclear physicians and researchers working on classification algorithms for thyroid pathologies.

6 June 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
ELEdith Falcon de Legal
Edith Falcon de Legal
MAMarta Ascurra
Marta Ascurra
RVRosa Vega-Paredes
Rosa Vega-Paredes
ESElis Sade
Elis Sade
MMMagna Monteiro
Magna Monteiro
ARAndreas Ries
Andreas Ries
Adrenal cortex carcinoma (ACC) in children is a rare tumor that is probably of multifactorial origin and is mainly associated with genetic and environmental alterations. In the south and part of the southeast of Brazil, as well as in the Paraguayan region bordering the Brazilian State of Paraná, ACC prevalence is higher than in any other country, which is associated with the high prevalence of the TP53 p.R337H variant in Paraná (0.30%), Santa Catarina (0.249%), cities around Campinas-SP (0.21%), and the Paraguayan cities on the border with Paraná (0.05%). Recent research suggests that the co-segregation of XAF1-E134* and TP53-R337H mutations leads to a more aggressive cancer phenotype than TP53-R337H alone. Breast cancer may be mildly influenced by co-segregation with XAF1 p.E134*, and this variant can also confer risk for sarcoma. Objectives: The objectives of this study were to (1) estimate the prevalence of the germline TP53 p.R337H and XAF1 p.E134* variants in Paraguay (excluding cities on the border with Paraná State, Brazil) and (2) estimate whether the ethnic origin of TP53 p.R337H carriers in Paraguay is similar to that of ethnic groups in Paraná (possible Portuguese/Spanish origin). Materials and methods: DNA tests for the identification of TP53 p.R337H were carried out from 2016 to 2019 at the Bio-Materials Laboratory of Facultad Politecnica, UNA, and at the Research Center in Biotechnology and Informatics (CEBIOTEC), Asunción, Paraguay. Polymerase chain reaction followed by restriction enzyme digestion (PCR-RFLP) was used to identify TP53 p.R337H, and real-time PCR (RT-PCR) was employed for XAF1 p.E134*. Peripheral blood samples from 40,000 Paraguayan newborns (NBs) were used for the TP53 p.R337H tests. The XAF1 p.E134* tests (RT-PCR) were performed on samples from 2000 Paraguayan newborns at the Pelé Pequeno Principe Research Institute, Curitiba, PR, Brazil. Results: The TP53 p.R337H variant was not found in any of the 14 Paraguayan departments investigated. A total of 12 of the 2000 Paraguayan NBs were positive for one XAF1 p.E134* allele. Conclusions: The hypothesis of Spanish immigrants carrying p.R337H to Paraguay was disproved. TP53 p.R337H neonatal testing in Paraguay is not recommended, except when there are families with Brazilian ancestry presenting cancer cases. Additional epidemiological studies are required to determine the likelihood of the identified prevalence of the XAF1 p.E134* allele (1/153) in NBs from Paraguay without TP53 p.R337H to present cancer risk. This study complements the first national initiative for the DNA screening of newborns aimed at mapping the TP53 p.R337H and XAF1 p.E134* variants in Paraguay (based on the regions of residence of the newborns).